Full Text of HB0680 95th General Assembly
HB0680eng 95TH GENERAL ASSEMBLY
|
|
|
HB0680 Engrossed |
|
LRB095 03973 KBJ 24006 b |
|
| 1 |
| AN ACT concerning public health.
| 2 |
| Be it enacted by the People of the State of Illinois,
| 3 |
| represented in the General Assembly:
| 4 |
| Section 1. Short title. This Act may be cited as the | 5 |
| Biomonitoring Feasibility Study Act. | 6 |
| Section 5. Findings and purposes. | 7 |
| (a) The General Assembly finds all of the following: | 8 |
| (1) An estimated 100,000 chemicals are on the U.S. | 9 |
| Environmental Protection Agency's Toxic Substances Control | 10 |
| Act inventory and thousands are in commerce today in the | 11 |
| United States. | 12 |
| (2) These chemicals are regulated by the U.S. | 13 |
| Environmental Protection Agency, in accordance with the | 14 |
| Toxic Substances Control Act. | 15 |
| (3) With advancements in analytical chemistry, | 16 |
| scientists can now detect minute quantities of chemicals in | 17 |
| humans.
| 18 |
| (4) Biomonitoring is one method for assessing human | 19 |
| exposure to chemicals by measuring the chemicals or their | 20 |
| breakdown products, known as metabolites, in human tissues | 21 |
| or specimens, such as blood and urine. In studies conducted | 22 |
| by the U.S. Centers for Disease Control and Prevention | 23 |
| (CDC), biomonitoring data has helped to identify chemicals |
|
|
|
HB0680 Engrossed |
- 2 - |
LRB095 03973 KBJ 24006 b |
|
| 1 |
| found in the environment and in human tissues, monitor | 2 |
| changes in human exposure to those chemicals, and | 3 |
| investigate the distribution of exposure among the general | 4 |
| population. The CDC has developed standardized and | 5 |
| validated analytical methods for measuring substances in | 6 |
| humans. The CDC's National Exposure Report provides | 7 |
| statistically valid distribution measurements of chemicals | 8 |
| in the U.S. population, including specific age, gender, and | 9 |
| ethnic groups. CDC continues to develop new validated | 10 |
| methods, and as they do so additional chemicals are being | 11 |
| reported. | 12 |
| (b) The purpose of this Act is for the University of | 13 |
| Illinois at Chicago (UIC), Great Lakes Center for Occupational | 14 |
| and Environmental Safety and Health to conduct an Environmental | 15 |
| Contaminant Biomonitoring Feasibility Study (Study) that | 16 |
| proposes the best way to establish an Illinois Environmental | 17 |
| Contaminant Biomonitoring Program (Program) that will do all of | 18 |
| the following: | 19 |
| (1) monitor the presence and concentration of | 20 |
| designated chemicals in a representative sample of the | 21 |
| population of this State; | 22 |
| (2) produce biomonitoring studies that provide data | 23 |
| for scientists, researchers, public health personnel, and | 24 |
| community members to explore potential linkages between | 25 |
| chemical exposure and health concerns; and
| 26 |
| (3) support Illinois public health by establishing |
|
|
|
HB0680 Engrossed |
- 3 - |
LRB095 03973 KBJ 24006 b |
|
| 1 |
| trends in chemical exposures, validating modeling and | 2 |
| survey methods, supporting epidemiological studies, | 3 |
| identifying highly exposed communities, addressing the | 4 |
| data gaps between chemical exposures and specific health | 5 |
| outcomes, informing health responses to unanticipated | 6 |
| emergency exposures, assessing the effectiveness of | 7 |
| current regulations, and setting priorities for research. | 8 |
| Section 10. Definitions. In this Act: | 9 |
| "Agency" means the Illinois Environmental Protection | 10 |
| Agency.
| 11 |
| "Department" means the Illinois Department of Public | 12 |
| Health. | 13 |
| "Panel" means the Scientific Guidance Panel.
| 14 |
| "Program" means the Illinois Environmental Contaminant | 15 |
| Biomonitoring Program. | 16 |
| "Study" means the Environmental Contaminant Biomonitoring | 17 |
| Feasibility Study. | 18 |
| Section 15. Scientific Guidance Panel. | 19 |
| (a) In implementing the Study, the Department and the | 20 |
| Agency shall establish a Scientific Guidance Panel. The | 21 |
| Directors of the Department and the Agency shall appoint the | 22 |
| members of the Panel. The Panel shall be composed of 11 | 23 |
| members, whose expertise shall encompass the disciplines of | 24 |
| public health, epidemiology, biostatistics, environmental |
|
|
|
HB0680 Engrossed |
- 4 - |
LRB095 03973 KBJ 24006 b |
|
| 1 |
| medicine, risk analysis, exposure assessment, developmental | 2 |
| biology, laboratory sciences, bioethics, maternal and child | 3 |
| health with a specialty in breastfeeding, and toxicology. | 4 |
| Members shall be appointed for 2-year terms. Members may be | 5 |
| reappointed for additional terms without limitation. Members | 6 |
| shall serve until their successors are appointed and have | 7 |
| qualified for membership on the Panel. Vacancies shall be | 8 |
| filled in the same manner as the original appointments, and any | 9 |
| member so appointed shall serve during the remainder of the | 10 |
| term for which the vacancy occurred. The Panel shall meet, at a | 11 |
| minimum, 3 times per year. The Agency shall be responsible for | 12 |
| staffing and administration of the Panel. Members of the Panel | 13 |
| shall be reimbursed for travel and other necessary expenses | 14 |
| incurred in the performance of their duties under this Act, but | 15 |
| shall not receive a salary or compensation. | 16 |
| (b) The Panel shall provide guidance to UIC and make | 17 |
| recommendations regarding the design and implementation of the | 18 |
| Program. The Panel shall recommend: | 19 |
| (1) scientifically sound Program design, rationale, | 20 |
| and procedures for selecting and collecting biological | 21 |
| samples and for selecting the populations for | 22 |
| biomonitoring, taking into account both ethical issues and | 23 |
| issues pertaining to confidentiality of data; | 24 |
| (2) scientifically sound, peer-reviewed procedures for | 25 |
| incorporating biomonitoring data into risk assessment | 26 |
| guidance, policies and regulations; |
|
|
|
HB0680 Engrossed |
- 5 - |
LRB095 03973 KBJ 24006 b |
|
| 1 |
| (3) procedures to accurately and effectively interpret | 2 |
| and communicate biomonitoring results within the context | 3 |
| of potential risks to human health; and
| 4 |
| (4) a procedure for selecting priority chemicals for | 5 |
| inclusion in the Program using sound public health | 6 |
| criteria, including all of the following criteria:
| 7 |
| (A) The degree of potential exposure to the public | 8 |
| or specific subgroups, including, but not limited to, | 9 |
| certain occupations. | 10 |
| (B) The likelihood of a chemical being a carcinogen | 11 |
| or toxicant based on peer-reviewed health data, its | 12 |
| chemical structure, or the toxicology of chemically | 13 |
| related compounds.
| 14 |
| (C) The availability and the limits of validated | 15 |
| laboratory detection for the chemical, including the | 16 |
| ability to reliably detect and quantify the chemical at | 17 |
| levels low enough to be expected in the general | 18 |
| population.
| 19 |
| (c) The Panel may recommend additional designated | 20 |
| chemicals not included in the National Report on Human Exposure | 21 |
| to Environmental Chemicals for inclusion in the Program using | 22 |
| all of the following criteria:
| 23 |
| (1) Exposure or potential exposure to the public or | 24 |
| specific subgroups. | 25 |
| (2) The known or suspected health effects resulting | 26 |
| from some level of exposure based on scientifically valid |
|
|
|
HB0680 Engrossed |
- 6 - |
LRB095 03973 KBJ 24006 b |
|
| 1 |
| studies. | 2 |
| (3) The need to assess the efficacy of public health | 3 |
| actions to reduce exposure to a chemical causally | 4 |
| associated with human health effects at environmentally | 5 |
| relevant exposure levels. | 6 |
| (4) The availability of a scientifically valid method | 7 |
| for accurately and reliably measuring the chemical in human | 8 |
| specimens.
| 9 |
| Section 20. Study report. Two years after the effective | 10 |
| date of this Act, UIC shall release a draft report for public | 11 |
| review and comment and for review by the Panel. The draft | 12 |
| report shall contain the findings of the Study and shall | 13 |
| include in the report recommended activities and estimated | 14 |
| costs of establishing the Program. The period for public | 15 |
| comment and review by the Panel shall last for 60 days. Within | 16 |
| 90 days of the close of the public comment period, the draft | 17 |
| report shall be revised, taking into consideration the comments | 18 |
| received and the recommendations of the Panel. The final report | 19 |
| shall be submitted to the Governor and General Assembly.
|
|